• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于优化临床前模型的原发性头颈肿瘤海绵支持培养。

Sponge-supported cultures of primary head and neck tumors for an optimized preclinical model.

作者信息

Dohmen Amy J C, Sanders Joyce, Canisius Sander, Jordanova Ekaterina S, Aalbersberg Else A, van den Brekel Michiel W M, Neefjes Jacques, Zuur Charlotte L

机构信息

Department of Head and Neck Oncology and Surgery, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.

Department of Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.

出版信息

Oncotarget. 2018 May 18;9(38):25034-25047. doi: 10.18632/oncotarget.25244.

DOI:10.18632/oncotarget.25244
PMID:29861851
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5982753/
Abstract

Treatment of advanced head and neck cancer is associated with low survival, high toxicity and a widely divergent individual response. The sponge-gel-supported histoculture model was previously developed to serve as a preclinical model for predicting individual treatment responses. We aimed to optimize the sponge-gel-supported histoculture model and provide more insight in cell specific behaviour by evaluating the tumor and its microenvironment using immunohistochemistry. We collected fresh tumor biopsies from 72 untreated patients and cultured them for 7 days. Biopsies from 57 patients (79%) were successfully cultured and 1451 tumor fragments (95.4%) were evaluated. Fragments were scored for percentage of tumor, tumor viability and proliferation, EGF-receptor expression and presence of T-cells and macrophages. Median tumor percentage increased from 53% at day 0 to 80% at day 7. Viability and proliferation decreased after 7 days, from 90% to 30% and from 30% to 10%, respectively. Addition of EGF, folic acid and hydrocortisone can lead to improved viability and proliferation, however this was not systematically observed. No patient subgroup could be identified with higher culture success rates. Immune cells were still present at day 7, illustrating that the tumor microenvironment is sustained. EGF supplementation did not increase viability and proliferation in patients overexpressing EGF-Receptor.

摘要

晚期头颈癌的治疗与低生存率、高毒性以及个体反应差异大有关。海绵凝胶支持的组织培养模型先前已被开发出来,用作预测个体治疗反应的临床前模型。我们旨在优化海绵凝胶支持的组织培养模型,并通过使用免疫组织化学评估肿瘤及其微环境,更深入地了解细胞的特定行为。我们从72名未经治疗的患者中收集了新鲜肿瘤活检样本,并将其培养7天。来自57名患者(79%)的活检样本成功培养,共评估了1451个肿瘤碎片(95.4%)。对碎片的肿瘤百分比、肿瘤活力和增殖、表皮生长因子受体表达以及T细胞和巨噬细胞的存在情况进行评分。肿瘤百分比中位数从第0天的53%增加到第7天的80%。7天后活力和增殖分别从90%降至30%和从30%降至10%。添加表皮生长因子、叶酸和氢化可的松可提高活力和增殖,但并非系统观察到这种情况。未发现培养成功率较高的患者亚组。免疫细胞在第7天仍然存在,这说明肿瘤微环境得以维持。在表皮生长因子受体过表达的患者中,补充表皮生长因子并未提高活力和增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb29/5982753/aa70d5ec01fa/oncotarget-09-25034-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb29/5982753/f392d8c23def/oncotarget-09-25034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb29/5982753/bd53eedbf382/oncotarget-09-25034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb29/5982753/98d54f90f0ba/oncotarget-09-25034-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb29/5982753/aa70d5ec01fa/oncotarget-09-25034-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb29/5982753/f392d8c23def/oncotarget-09-25034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb29/5982753/bd53eedbf382/oncotarget-09-25034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb29/5982753/98d54f90f0ba/oncotarget-09-25034-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb29/5982753/aa70d5ec01fa/oncotarget-09-25034-g004.jpg

相似文献

1
Sponge-supported cultures of primary head and neck tumors for an optimized preclinical model.用于优化临床前模型的原发性头颈肿瘤海绵支持培养。
Oncotarget. 2018 May 18;9(38):25034-25047. doi: 10.18632/oncotarget.25244.
2
Histoculture and the immunodeficient mouse come to the cancer clinic - rational approaches to individualizing cancer-therapy and new drug-evaluation (review).组织培养与免疫缺陷小鼠走进癌症诊所——个体化癌症治疗与新药评估的合理方法(综述)
Int J Oncol. 1992 Sep;1(4):467-74. doi: 10.3892/ijo.1.4.467.
3
Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation.在水凝胶微孔阵列中生成均匀的3D微肿瘤用于活力、形态学和信号通路激活的测量
Assay Drug Dev Technol. 2015 Nov;13(9):570-83. doi: 10.1089/adt.2015.662. Epub 2015 Aug 14.
4
Human-in-mouse modeling of primary head and neck squamous cell carcinoma.原发性头颈部鳞状细胞癌的人源化小鼠模型。
Laryngoscope. 2009 Dec;119(12):2315-23. doi: 10.1002/lary.20607.
5
3D Sponge-Matrix Histoculture: An Overview.3D海绵基质组织培养:概述
Methods Mol Biol. 2018;1760:11-17. doi: 10.1007/978-1-4939-7745-1_2.
6
The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.头颈部癌和正常组织中的表皮生长因子受体系统。免疫组织化学和定量研究。
Dan Med Bull. 1998 Apr;45(2):121-34.
7
[The effect of the microenvironment of head and neck cancers on tumor progression].[头颈部癌症的微环境对肿瘤进展的影响]
Magy Onkol. 2009 Mar;53(1):51-9. doi: 10.1556/MOnkol.53.2009.1.8.
8
Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.局部晚期头颈部鳞状细胞癌患者的 T 细胞受体谱及免疫微环境特征。
Clin Cancer Res. 2017 Aug 15;23(16):4897-4907. doi: 10.1158/1078-0432.CCR-17-0103. Epub 2017 Apr 25.
9
Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.Notch1表达与激活和头颈部鳞状细胞癌顺铂敏感性的相关性
Ai Zheng. 2009 Feb;28(2):100-3. Epub 2009 Feb 23.
10
Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression.基于表皮生长因子(EGF)受体配体的分子分期可预测头颈部鳞状细胞癌的预后,部分原因是EGF诱导的双调蛋白表达失调。
J Exp Clin Cancer Res. 2016 Sep 26;35(1):151. doi: 10.1186/s13046-016-0422-z.

引用本文的文献

1
In Vitro Models of Head and Neck Cancer: From Primitive to Most Advanced.头颈癌的体外模型:从原始到最先进
J Pers Med. 2023 Nov 3;13(11):1575. doi: 10.3390/jpm13111575.
2
Patient-derived three-dimensional culture techniques model tumor heterogeneity in head and neck cancer.患者来源的三维培养技术可模拟头颈部癌症的肿瘤异质性。
Oral Oncol. 2023 Mar;138:106330. doi: 10.1016/j.oraloncology.2023.106330. Epub 2023 Feb 9.
3
Making In Vitro Tumor Models Whole Again.让体外肿瘤模型恢复完整。

本文引用的文献

1
Preclinical models in HNSCC: A comprehensive review.头颈部鳞状细胞癌的临床前模型:全面综述
Oral Oncol. 2017 Feb;65:51-56. doi: 10.1016/j.oraloncology.2016.12.010. Epub 2016 Dec 28.
2
Efficient and simple approach to in vitro culture of primary epithelial cancer cells.原发性上皮癌细胞体外培养的高效简易方法。
Biosci Rep. 2016 Dec 9;36(6). doi: 10.1042/BSR20160208. Print 2016 Dec.
3
Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.靶向头颈部鳞状细胞癌的肿瘤微环境
Adv Healthc Mater. 2023 Jun;12(14):e2202279. doi: 10.1002/adhm.202202279. Epub 2023 Feb 22.
4
Modern Approaches to Testing Drug Sensitivity of Patients' Tumors (Review).现代方法检测患者肿瘤的药物敏感性(综述)。
Sovrem Tekhnologii Med. 2021;12(4):91-102. doi: 10.17691/stm2020.12.4.11. Epub 2020 Aug 27.
5
Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer.精准医学蓬勃发展:头颈部癌症中的新型3D模型和基于干细胞的方法
Front Cell Dev Biol. 2021 Jul 8;9:666515. doi: 10.3389/fcell.2021.666515. eCollection 2021.
6
Ex Vivo Culture Models to Indicate Therapy Response in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌治疗反应的体外培养模型。
Cells. 2020 Nov 23;9(11):2527. doi: 10.3390/cells9112527.
Curr Treat Options Oncol. 2016 Jul;17(7):37. doi: 10.1007/s11864-016-0412-6.
4
Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.头颈部癌原发性肿瘤培养模型及临床前预测分析的可行性:一项叙述性综述
Cancers (Basel). 2015 Aug 28;7(3):1716-42. doi: 10.3390/cancers7030858.
5
Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC.非小细胞肺癌患者中M1/M2肿瘤相关巨噬细胞(TAM)及Th1/Th2细胞因子谱的特征分析
Cancer Microenviron. 2016 Apr;9(1):1-11. doi: 10.1007/s12307-015-0174-x. Epub 2015 Aug 30.
6
The prognostic landscape of genes and infiltrating immune cells across human cancers.人类癌症中基因与浸润性免疫细胞的预后情况
Nat Med. 2015 Aug;21(8):938-945. doi: 10.1038/nm.3909. Epub 2015 Jul 20.
7
Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas.头颈部癌的肿瘤内基因异质性与死亡率:来自癌症基因组图谱的数据分析
PLoS Med. 2015 Feb 10;12(2):e1001786. doi: 10.1371/journal.pmed.1001786. eCollection 2015 Feb.
8
Overexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genes.在头颈部鳞状细胞癌中,EGFR 的过度表达与 SH3GL2 和 CDC25A 基因的失活有关。
PLoS One. 2013 May 10;8(5):e63440. doi: 10.1371/journal.pone.0063440. Print 2013.
9
The immune contexture in human tumours: impact on clinical outcome.人类肿瘤中的免疫结构:对临床结果的影响。
Nat Rev Cancer. 2012 Mar 15;12(4):298-306. doi: 10.1038/nrc3245.
10
Human papillomavirus status in young patients with head and neck squamous cell carcinoma.头颈部鳞状细胞癌年轻患者的人乳头瘤病毒状态。
Int J Cancer. 2012 Apr 15;130(8):1806-12. doi: 10.1002/ijc.26195. Epub 2011 Aug 2.